Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Is Pfizer's Acquisition of Arena a Good Move for Investors?
Is Pfizer's Acquisition of Arena a Good Move for Investors?
Is Pfizer's Acquisition of Arena a Good Move for Investors?
Submitted by
admin
on January 3, 2022 - 10:33am
Source:
Motley Fool
News Tags:
Pfizer
Arena Pharmaceuticals
M&A
Headline:
Is Pfizer's Acquisition of Arena a Good Move for Investors?
snippet:
Pfizer plans to acquire Arena for $6.7 billion.
Arena's pipeline appears to be a good fit for Pfizer.
The price tag of the deal also seems reasonable for Pfizer, but maybe not for some Arena shareholders.
Do Not Allow Advertisers to Use My Personal information
